Cargando…
The In Vitro Adaptation of Patient-Derived Organoids Suggests Alternative Strategies against CMS1 Colorectal Cancer: When the Microenvironment Does Make the Difference
Autores principales: | Poggi, Alessandro, Matis, Serena, Benelli, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775687/ https://www.ncbi.nlm.nih.gov/pubmed/36551571 http://dx.doi.org/10.3390/cancers14246086 |
Ejemplares similares
-
microRNAs in Liquid Biopsy: The Way to a Simple and Rapid Test for Early Colorectal Cancer Diagnosis?
por: Matis, Serena, et al.
Publicado: (2023) -
Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab
por: Benelli, Roberto, et al.
Publicado: (2022) -
How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
por: Poggi, Alessandro, et al.
Publicado: (2018) -
Corrigendum: How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
por: Poggi, Alessandro, et al.
Publicado: (2018) -
The Pleiotropic Effects of Gut Microbiota in Colorectal Cancer Progression: How to Turn Foes into Friends
por: Tardito, Samuele, et al.
Publicado: (2023)